Relmada Therapeutics, Inc. is in its Venus mahadasha (3 Feb 2018 to 3 Feb 2038), Rahu antardasha (5 Apr 2025 to 5 Apr 2028) and Mercury pratyantar (2 Aug 2026 to 4 Jan 2027).
Next: pratyantar Ketu from 4 Jan 2027; antardasha Jupiter from 5 Apr 2028; mahadasha Sun from 3 Feb 2038.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Kanya (Virgo) | 22°08′ | 12th | Hasta 4 |
| Moon | Mesha (Aries) | 7°00′ | 7th | Ashwini 3 |
| Mars | Vrishchika (Scorpio) | 23°42′ | 2nd | Jyeshtha 3 |
| Mercury (R) | Tula (Libra) | 6°47′ | 1st | Swati 1 |
| Jupiter | Karka (Cancer) | 23°18′ | 10th | Ashlesha 2 |
| Venus | Kanya (Virgo) | 18°03′ | 12th | Hasta 3 |
| Saturn | Tula (Libra) | 27°20′ | 1st | Vishakha 3 |
| Rahu | Kanya (Virgo) | 25°19′ | 12th | Chitra 1 |
| Ketu | Meena (Pisces) | 25°19′ | 6th | Revati 3 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how RLMD moved in each period against the S&P 500, transits, fundamentals and news.